NVIDIA Corporation Common StockNVDA
Closing prices as of Oct 23, 2026Updated once daily after the US close — not a live quote.

$211.11

-5.40% past month

Notable price movement

  • Oct 23, 2026

    $210.96-0.59%

    Nvidia closed down 0.59% while comparable semiconductor companies rose 1.29% on average, with 5 of 6 rising . The move was therefore not shared by the cohort. The other items were opinion pieces or coverage of other companies, so they do not explain the decline.

  • Oct 22, 2026

    $212.21-4.40%

    Comparable semiconductor companies fell 6.11% on average, with all 6 lower . Nvidia's 4.40% decline came alongside that cohort-wide drop, though it fell by less than the cohort average .

  • Oct 21, 2026

    $221.97+2.54%

    Comparable semiconductor companies rose 1.86% on average, with all 6 higher . Nvidia's 2.54% gain came alongside that cohort-wide advance .

  • Oct 20, 2026

    $216.47-0.29%

  • Oct 19, 2026

    $217.09+1.38%

    Comparable semiconductor companies rose 1.62% on average, with 5 of 6 higher . Nvidia's 1.38% gain came alongside that sector move. Globenewswire also reported that NVIDIA ran a record simulation of fault-tolerant quantum computing at the Jülich Supercomputing Centre .

  • Oct 16, 2026

    $214.13-1.43%

    Nvidia fell 1.43%, a smaller drop than its semiconductor peers. Comparable semiconductor companies fell 4.61% on average, and all 6 of them declined . Globenewswire carried a headline that NVIDIA RTX Spark PCs were available that day . Seeking Alpha's market wrap said the Nasdaq lost 4% on the week .

  • Oct 15, 2026

    $217.23-1.84%

    Nvidia fell 1.84%, while comparable semiconductor companies fell 1.21% on average, with 5 of 6 lower . Nvidia's decline was somewhat larger than the cohort's average. Seeking Alpha described a Nasdaq recovery after AI investors took profits that day .

Closing prices for NVDA. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Prices and financial data are historical and provided for research only. Not investment advice.